PL2415463T3 - Kompozycja lecznicza w postaci cząstek stałych - Google Patents
Kompozycja lecznicza w postaci cząstek stałychInfo
- Publication number
- PL2415463T3 PL2415463T3 PL11711242T PL11711242T PL2415463T3 PL 2415463 T3 PL2415463 T3 PL 2415463T3 PL 11711242 T PL11711242 T PL 11711242T PL 11711242 T PL11711242 T PL 11711242T PL 2415463 T3 PL2415463 T3 PL 2415463T3
- Authority
- PL
- Poland
- Prior art keywords
- medicinal composition
- particulate medicinal
- particulate
- composition
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010029486A JP4653242B1 (ja) | 2010-02-12 | 2010-02-12 | 粒子状医薬組成物 |
| EP11711242.5A EP2415463B1 (en) | 2010-02-12 | 2011-02-14 | Particulate medicinal composition |
| PCT/JP2011/053052 WO2011099601A1 (ja) | 2010-02-12 | 2011-02-14 | 粒子状医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2415463T3 true PL2415463T3 (pl) | 2016-06-30 |
Family
ID=43952737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11711242T PL2415463T3 (pl) | 2010-02-12 | 2011-02-14 | Kompozycja lecznicza w postaci cząstek stałych |
| PL15159795T PL2918267T3 (pl) | 2010-02-12 | 2011-02-14 | Kompozycja farmaceutyczna w postaci cząstek stałych |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15159795T PL2918267T3 (pl) | 2010-02-12 | 2011-02-14 | Kompozycja farmaceutyczna w postaci cząstek stałych |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9198860B2 (pl) |
| EP (2) | EP2415463B1 (pl) |
| JP (1) | JP4653242B1 (pl) |
| KR (2) | KR101612876B1 (pl) |
| CN (1) | CN102753151B (pl) |
| AU (1) | AU2011215177B2 (pl) |
| CA (1) | CA2785858C (pl) |
| DK (2) | DK2415463T3 (pl) |
| ES (2) | ES2560810T3 (pl) |
| PL (2) | PL2415463T3 (pl) |
| PT (2) | PT2415463E (pl) |
| WO (1) | WO2011099601A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2842546A4 (en) * | 2012-04-27 | 2015-12-30 | Univ Tokyo | PHARMACEUTICAL COMPOSITION WITH UNIT STRUCTURE FOR NUCLEIC ACID RELIEF |
| WO2016137006A1 (ja) * | 2015-02-27 | 2016-09-01 | ナノキャリア株式会社 | ポリマーミセル担体組成物およびポリマーミセル組成物 |
| CN111050752B (zh) | 2017-08-31 | 2022-08-16 | 国立大学法人东京大学 | 搭载核酸的单元型聚离子复合物 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02121932A (ja) * | 1988-10-29 | 1990-05-09 | Res Inst For Prod Dev | ヘモグロビン含有リポソーム、その製造方法および該製造方法用の原液 |
| KR940003548U (ko) | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
| FR2759298B1 (fr) * | 1997-02-10 | 1999-04-09 | Rhone Poulenc Rorer Sa | Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees |
| US6884430B1 (en) | 1997-02-10 | 2005-04-26 | Aventis Pharma S.A. | Formulation of stabilized cationic transfection agent(s) /nucleic acid particles |
| TWI225412B (en) | 1997-06-23 | 2004-12-21 | Sequus Pharm Inc | Liposome-entrapped polynucleotide composition and method |
| EP1043030A4 (en) | 1997-12-26 | 2007-05-02 | Astellas Pharma Inc | MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE |
| JP2000302685A (ja) * | 1999-02-18 | 2000-10-31 | Sankyo Co Ltd | 抗腫瘍薬含有リポソーム製剤 |
| DE19954843C2 (de) | 1999-11-09 | 2003-11-20 | Novosom Ag | Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung |
| JP3942362B2 (ja) * | 2000-02-02 | 2007-07-11 | アンジェスＭｇ株式会社 | 遺伝子導入のためのウイルスエンベロープベクター |
| EP1170363B1 (en) | 2000-02-02 | 2007-11-21 | Kaneda, Yasufumi | Virus envelope vector for gene transfer |
| FR2814951B1 (fr) | 2000-10-06 | 2003-01-17 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation |
| JP4063510B2 (ja) * | 2001-07-13 | 2008-03-19 | ナノキャリア株式会社 | 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤 |
| ATE345780T1 (de) | 2001-07-13 | 2006-12-15 | Nanocarrier Co Ltd | Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung |
| JP4294946B2 (ja) * | 2002-12-13 | 2009-07-15 | 富士フイルム株式会社 | 標的検出装置及び標的検出方法並びに標的検出用基材 |
| JP4917263B2 (ja) * | 2002-12-23 | 2012-04-18 | バイカル インコーポレイテッド | 核酸／ブロックコポリマー／陽イオン性界面活性剤複合体を凍結乾燥する方法 |
| JPWO2005092389A1 (ja) | 2004-03-10 | 2007-08-16 | 協和醗酵工業株式会社 | 複合粒子および被覆複合粒子 |
| AU2005259799A1 (en) | 2004-07-02 | 2006-01-12 | Protiva Biotherapeutics, Inc. | Immunostimulatory siRNA molecules and uses therefor |
| WO2006060723A2 (en) * | 2004-12-03 | 2006-06-08 | Vical Incorporated | Methods for producing block copolymer/amphiphilic particles |
| US20090258079A1 (en) | 2005-05-10 | 2009-10-15 | Ryoichi Katakai | Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof |
| JP2006321763A (ja) * | 2005-05-20 | 2006-11-30 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | 生体適合性ナノ粒子及びその製造方法 |
| JP2007099631A (ja) | 2005-09-30 | 2007-04-19 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | アニオン性薬物封入ナノ粒子の製造方法及びそれを用いた医薬製剤 |
| WO2007136134A1 (ja) * | 2006-05-23 | 2007-11-29 | Nanocarrier Co., Ltd. | 疎水性薬物内包ポリマーミセルの製造方法 |
| BRPI0714718B1 (pt) * | 2006-07-18 | 2018-05-15 | Nanocarrier Co., Ltd. | Composição de micela polimérica de encapsulamento de polipeptídeos ou proteínas e seu método de preparo |
| US20080311040A1 (en) * | 2007-03-06 | 2008-12-18 | Flagship Ventures | METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| JP2009200681A (ja) | 2008-02-20 | 2009-09-03 | Seiko Instruments Inc | 近接検出装置および近接検出方法 |
| US20110268772A1 (en) * | 2008-12-26 | 2011-11-03 | Samyang Corporation | Pharmaceutical composition containing an anionic drug and a production method thereof |
-
2010
- 2010-02-12 JP JP2010029486A patent/JP4653242B1/ja not_active Expired - Fee Related
-
2011
- 2011-02-14 ES ES11711242.5T patent/ES2560810T3/es active Active
- 2011-02-14 DK DK11711242.5T patent/DK2415463T3/en active
- 2011-02-14 KR KR1020127017814A patent/KR101612876B1/ko not_active Expired - Fee Related
- 2011-02-14 AU AU2011215177A patent/AU2011215177B2/en not_active Ceased
- 2011-02-14 CN CN201180009063.8A patent/CN102753151B/zh not_active Expired - Fee Related
- 2011-02-14 WO PCT/JP2011/053052 patent/WO2011099601A1/ja not_active Ceased
- 2011-02-14 PL PL11711242T patent/PL2415463T3/pl unknown
- 2011-02-14 KR KR1020167008609A patent/KR101839545B1/ko not_active Expired - Fee Related
- 2011-02-14 US US13/122,546 patent/US9198860B2/en not_active Expired - Fee Related
- 2011-02-14 PL PL15159795T patent/PL2918267T3/pl unknown
- 2011-02-14 DK DK15159795.2T patent/DK2918267T3/en active
- 2011-02-14 ES ES15159795.2T patent/ES2636778T3/es active Active
- 2011-02-14 EP EP11711242.5A patent/EP2415463B1/en not_active Not-in-force
- 2011-02-14 CA CA2785858A patent/CA2785858C/en not_active Expired - Fee Related
- 2011-02-14 PT PT117112425T patent/PT2415463E/pt unknown
- 2011-02-14 EP EP15159795.2A patent/EP2918267B1/en not_active Not-in-force
- 2011-02-14 PT PT151597952T patent/PT2918267T/pt unknown
-
2015
- 2015-11-02 US US14/930,119 patent/US9795563B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2636778T3 (es) | 2017-10-09 |
| WO2011099601A1 (ja) | 2011-08-18 |
| AU2011215177A1 (en) | 2012-07-05 |
| US20120076866A1 (en) | 2012-03-29 |
| CN102753151B (zh) | 2014-08-06 |
| KR101612876B1 (ko) | 2016-04-18 |
| CA2785858A1 (en) | 2011-08-18 |
| PT2415463E (pt) | 2016-03-22 |
| EP2415463A1 (en) | 2012-02-08 |
| KR101839545B1 (ko) | 2018-03-16 |
| US9795563B2 (en) | 2017-10-24 |
| EP2918267A1 (en) | 2015-09-16 |
| JP4653242B1 (ja) | 2011-03-16 |
| CN102753151A (zh) | 2012-10-24 |
| KR20160041057A (ko) | 2016-04-15 |
| DK2918267T3 (en) | 2017-07-10 |
| EP2918267B1 (en) | 2017-05-10 |
| US9198860B2 (en) | 2015-12-01 |
| CA2785858C (en) | 2016-04-26 |
| EP2415463B1 (en) | 2016-01-13 |
| JP2011162512A (ja) | 2011-08-25 |
| DK2415463T3 (en) | 2016-04-11 |
| PL2918267T3 (pl) | 2017-09-29 |
| US20160058703A1 (en) | 2016-03-03 |
| EP2415463A4 (en) | 2012-02-29 |
| ES2560810T3 (es) | 2016-02-22 |
| KR20120113754A (ko) | 2012-10-15 |
| PT2918267T (pt) | 2017-06-22 |
| AU2011215177B2 (en) | 2015-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245326A0 (en) | pharmaceutical preparation | |
| PL2619182T3 (pl) | Kompozycja farmaceutyczna | |
| IL225457A0 (en) | Pharmaceutical composition | |
| ZA201304189B (en) | Novel pharmaceutical composition | |
| PT2579858E (pt) | Composição farmacêutica que contém ivabradina | |
| ZA201301920B (en) | Pharmaceutical composition | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| IL226554A (en) | Medicinal preparations containing alisporiovir | |
| IL221501A (en) | Medicinal product containing miramistine | |
| PT2415463E (pt) | Composição medicinal em partículas | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| EP2560678A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB201019775D0 (en) | Pharmaceutical composition | |
| HU1000006D0 (en) | Improved pharmaceutical composition |